Affordable Access

deepdyve-link deepdyve-link
Publisher Website

The virological response in Koreans infected with HCV genotype 1 did not differ between groups treated with a full dose or reduced dose (≥80 % full dose) of peginterferon alfa-2a: a prospective randomized multicenter trial.

Authors
Type
Published Article
Journal
Hepatology international
Publication Date
Volume
7
Issue
4
Pages
1000–1009
Identifiers
DOI: 10.1007/s12072-013-9472-x
PMID: 26202029
Source
Medline
Keywords
License
Unknown

Abstract

In Koreans with HCV genotype 1, the virological response to treatment did not differ between a full dose and reduced dose (≥80 % of full dose) of peginterferon alfa-2a. However, in the patients with unfavorable IL28B genotypes, the full-dose treatment of peginterferon alfa-2a may be beneficial.

Statistics

Seen <100 times